At a glance
- Originator Merck Frosst
- Class Analgesics; Antipyretics; Antiulcers; Nonsteroidal anti-inflammatories; Small molecules; Triazoles
- Mechanism of Action Cyclo-oxygenase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation; Pain
Most Recent Events
- 08 Oct 2001 No-Development-Reported for Inflammation in Canada (Unknown route)
- 08 Oct 2001 No-Development-Reported for Inflammation in United Kingdom (Unknown route)
- 08 Oct 2001 No-Development-Reported for Inflammation in USA (Unknown route)